CClinicalTrials.gg
Active, not recruitingNCT04713449Updated Feb 23, 2026

Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial

An interventional study of Empowered Survivor Online and Springboard Beyond Cancer in Oral Cancer, Oropharyngeal Cancer and Head and Neck Cancer, sponsored by Rutgers, The State University of New Jersey. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-02-23.

Sponsored by Rutgers, The State University of New Jersey · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
643
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

Project's goal is evaluate an online tool the research team created called Empowered Survivor (ES) against a free online self-management intervention developed for cancer survivors by the National Cancer Institute and the American Cancer Society called Springboard Beyond Cancer.

Read the detailed description

600 patients who have completed treatment between one and three years ago and are currently cancer-free will be recruited via the New Jersey State Cancer Registry or the Cancer Registry of Greater California and randomly assigned to ES or Springboard Beyond Cancer. Participants will complete measures at baseline, 2, and 6-months post-baseline. The investigators will also complete a process evaluation of Empowered Survivor.

02

Conditions studied

  • Oral Cancer
  • Oropharyngeal Cancer
  • Head and Neck Cancer
03

In context

Mouth Neoplasms

377 studies on the registry are indexed under Mouth Neoplasms; 126 are open to participants now.

This study's enrollment of 643 is above the median of 65 across 265 interventional studies indexed under Mouth Neoplasms.

Browse Mouth Neoplasms studies →

Lead sponsor

Rutgers, The State University of New Jersey is the lead sponsor of 496 studies on the registry; 130 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 30 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age > 18 years;
  • Diagnosed with a first primary invasive oral or oropharyngeal cancer between 1 and 3 years ago;
  • Currently cancer free (but can have experienced a recurrence);
  • Has internet access;
  • Read English;
  • Has sufficient vision to read a survey and complete an online intervention

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
643 participants (actual)

Study arms

  • Experimental
    Empowered Survivor online

    The online intervention, called Empowered Survivor (ES) is a self-management intervention for patients with head and neck cancer. The intervention contains the following modules: Introduction; Difficulty Swallowing and Muscle Strength; Oral Care; Long-term Follow-Up Care/Oral exams; Calm and Connect; and Maintaining.

    Other: Empowered Survivor Online · Other: Survey Administration

  • Active comparator
    Springboard Beyond Cancer

    Springboard Beyond Cancer is a general resource for survivors of all cancer. It is a free self-management program for cancer survivors developed by trusted sources, the ACS and the NCI.

    Other: Springboard Beyond Cancer · Other: Survey Administration

Interventions

  • OtherEmpowered Survivor Online

    Informational online intervention for head and neck cancer survivors

  • OtherSpringboard Beyond Cancer

    Informational online intervention for all cancer survivors

  • OtherSurvey Administration

    Survey measures administered at BL, two and 6 months post-baseline

06

What researchers measure

Primary outcomes

  1. Self-efficacy score

    Change in self- efficacy measured with the Self-efficacy scale (22 items) which targets confidence in managing aspects of self-care (e.g., dry mouth, swallowing, oral self-exam, communicating with providers, emotions). Administered at multiple time points to measure effect of the intervention. Ratings range from 1 (not at all confident) to 5 (very confident). An item average will be calculated.

    Time frame: Baseline, two and 6 months post-baseline

  2. Preparedness for survivorship

    Change in preparedness for survivorship. The Preparedness for survivorship scale (10 items) developed by the investigator assesses whether information received about survivorship was sufficient, helpful, comprehensive, and covered self-care tasks. Administered at multiple time points to measure effect of the intervention. Items are rated on a 4-point Likert scale (1 = strongly disagree, 4 = strongly agree). Higher score indicate better preparedness.

    Time frame: Baseline, two and 6 months post-baseline

  3. Quality of Life score measured using the The European Organization for Research and Treatment of Cancer (EORTC)- Head and Neck

    Change in QOL score over time. The European Organization for Research and Treatment of Cancer - Quality of Life Questionnaire- Head and Neck-43. The European Organization for Research and Treatment of Cancer - Quality of Life Questionnaire- Head and Neck-43 is the updated version of the EORTC H\&N 35, used in the researcher's pilot work. The EORTC QLQ-HN is the most widely-used measure of Head and Neck QOL. The investigators use the total score in analyses, but will evaluate subscales. Administered at multiple time points to measure effect of the intervention. Items are rated on 1 (not at all)-4 (very much) Likert scale and higher scores indicate worse QOL.

    Time frame: Baseline, two and 6 months post-baseline

Secondary outcomes

  1. Performance of oral self-exam, past month

    1 item asking the participant if he/she has performed an oral self-exam, past month. Yes/No. Administered at multiple time points to measure effect of the intervention.

    Time frame: Baseline, two and 6 months post-baseline

  2. Comprehensiveness is the number of areas checked (11 areas) during the oral self-exam

    Change in comprehensiveness of exams over time. 11 items will list the areas to check and ask participant to indicate Yes/No if the participant checked that area during the oral self-exam. Administered at multiple time points to measure effect of the intervention.

    Time frame: Baseline, two and 6 months post-baseline

  3. Performance of exercises to improve swallowing, past month (yes/no)

    One question asking participants if they have completed exercises to improve swallowing in the past month. Administered at multiple time points to measure effect of the intervention.

    Time frame: Baseline, two and 6 months post-baseline

  4. Performance of head/neck exercises, past month (yes/no)

    One question asking participants if they have completed head and neck exercises in the past month. Administered at multiple time points to measure effect of the intervention.

    Time frame: Baseline, two and 6 months post-baseline

Other outcomes

  1. Action and Planning Coping

    Change in Action and Planning coping score. The scale (8 items) assesses the degree to which a detailed plan is made for self-care tasks. Administered at multiple time points to measure effect of the intervention. Items are rated on a 5-point Likert scale(1 = strongly disagree, 5 = strongly agree). Mean scale score will be reported. Higher score = higher action coping.

    Time frame: Baseline, two and 6 months post-baseline

  2. Patient activation

    Change in Patient activation scale score. Patient Activation Scale (13 items) assesses the active role in cancer care. Administered at multiple time points to measure effect of the intervention. Items are rated on a 4-point scale (1 = Disagree strongly, 4 = Agree strongly). Higher score = higher activation.

    Time frame: Baseline, two and 6 months post-baseline

  3. Information Needs

    Change in score over time. Information needs (23 items) is adapted from the FOCUS Health-Related Topics measure. Administered at multiple time points to measure effect of the intervention. Participants reported if they would like more information on each topic (yes/no). The number of " yes" responses are averaged.

    Time frame: Baseline, two and 6 months post-baseline

  4. Support needs

    Change in Support needs. The support needs scale (34 items) assesses physical, psychological, and health care needs. Administered at multiple time points to measure effect of the intervention. Participants are asked to indicate the extent to which they needed help in the past month (1 = No Need; Not applicable, "This is not a problem",2 = No need; Satisfied, "I did need help but my need was satisfied," 3 = Low need; "It caused me concern and I had little need for additional help," 4 = Moderate need-"It caused me concern and I had some need for additional help," 5 = High need; -"It caused me concern and I had a strong need for additional help"). Support needs that are rated as "moderate"(4) or "high" need (5) will be summed, with a range of 0 to 34.

    Time frame: Baseline, two and 6 months post-baseline

  5. Concerns about recurrence scale

    Change in concerns about recurrence. The first 4 items from the concerns about recurrence scale are measured on a 1-6 scale. with lower scores indicating less concerns or worry. The additional 21 items are rated on 0 (not at all) to 4 (extremely) with higher scores indicating more concerns or worry. Administered at multiple time points to measure effect of the intervention.

    Time frame: Baseline, two and 6 months post-baseline

  6. Moderator-Race/ethnicity

    Race/ethnicity will be assessed.

    Time frame: Baseline only

  7. Moderator-Receipt of survivorship care plan

    Yes/No did the participant receive a survivorship care plan

    Time frame: Baseline only

  8. Moderator- Baseline self-efficacy score

    The baseline score on the scale will be (22 items) examined. The scale targets confidence in managing aspects of self-care (e.g., dry mouth, swallowing, oral self-exam, communicating with providers, emotions). Ratings are 1- 5

    Time frame: Baseline Only

07

Study locations

1 site
  • Rutgers Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901, United States
08

References and documents

Publications

  • Manne SL, Imanguli M, Kashy D, Pesanelli M, Frederick S, Van Cleave JH, Paddock L, Hudson S, Steinberg M, Clifford P, Domider M, Singh N. Enhancing Self-care Among Oral Cancer Survivors: Protocol for the Empowered Survivor Trial. JMIR Res Protoc. 2023 Jan 20;12:e39996. doi: 10.2196/39996. PubMed 36662561 ↗

Study documents

  • Informed consent form · May 9, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04713449
Lead sponsor
Rutgers, The State University of New Jersey
Collaborators
National Cancer Institute (NCI), The Cancer Registry of Greater California, The New Jersey State Cancer Registry
Responsible party
Sharon Manne, PhD (Chief, Behavioral Sciences, Rutgers, The State University of New Jersey) — Principal investigator
First posted
Jan 19, 2021
Start date
Jan 19, 2021
Primary completion
Aug 28, 2025
Completion
Feb 28, 2027 (estimated)
Last update
Feb 23, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion